Status:
COMPLETED
Marrow Mesenchymal Cell Therapy for Osteogenesis Imperfecta: A Pilot Study
Lead Sponsor:
St. Jude Children's Research Hospital
Conditions:
Osteogenesis Imperfecta
Eligibility:
All Genders
Phase:
NA
Brief Summary
Osteogenesis imperfecta (OI) is a genetic disease for which there is currently no known cure. OI causes the osteoblasts (bone-forming cells in the body) to grow poorly, which slows the growth of child...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Must have been previously enrolled on TOIT protocol at St. Jude Children's Research Hospital
- Must have original bone marrow donor available and willing to participate as a donor
- Normal liver function
- Hemoglobin \>10gm/dl
Exclusion
Key Trial Info
Start Date :
March 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2007
Estimated Enrollment :
9 Patients enrolled
Trial Details
Trial ID
NCT00187018
Start Date
March 1 2004
End Date
August 1 2007
Last Update
March 4 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St. Jude Children's Research Hospital
Memphis, Tennessee, United States, 38105